Observational studyBMC cancer2025

The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors.

Gwenn Le Gall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.